Air Force 460 ALLINONE - Aspirateur balai ROWENTA - Notice d'utilisation et mode d'emploi gratuit
Retrouvez gratuitement la notice de l'appareil Air Force 460 ALLINONE ROWENTA au format PDF.
| Caractéristiques | Détails |
|---|---|
| Type d'appareil | Balai sans fil |
| Puissance | 25,2 V |
| Autonomie | Jusqu'à 60 minutes |
| Temps de charge | 4 heures |
| Capacité du réservoir | 0,5 L |
| Poids | 2,5 kg |
| Accessoires inclus | Brosse motorisée, suceur long, brosse douce |
| Utilisation | Convient pour tous types de sols, idéal pour les poils d'animaux |
| Maintenance | Filtre lavable, réservoir facile à vider |
| Sécurité | Protection contre la surchauffe |
| Informations générales | Éclairage LED sur la tête d'aspiration, design ergonomique |
FOIRE AUX QUESTIONS - Air Force 460 ALLINONE ROWENTA
Questions des utilisateurs sur Air Force 460 ALLINONE ROWENTA
0 question sur cet appareil. Repondez a celles que vous connaissez ou posez la votre.
Poser une nouvelle question sur cet appareil
Téléchargez la notice de votre Aspirateur balai au format PDF gratuitement ! Retrouvez votre notice Air Force 460 ALLINONE - ROWENTA et reprennez votre appareil électronique en main. Sur cette page sont publiés tous les documents nécessaires à l'utilisation de votre appareil Air Force 460 ALLINONE de la marque ROWENTA.
MODE D'EMPLOI Air Force 460 ALLINONE ROWENTA
FIG. 1 The association between the level of conjugation and the number of mutations in the human genome. (A) The association between the level of conjugation and the number of mutations in the human genome. (B) The association between the level of conjugation and the number of mutations in the human genome. (C) The association between the level of conjugation and the number of mutations in the human genome. (D) The association between the level of conjugation and the number of mutations in the human genome. (E) The association between the level of conjugation and the number of mutations in the human genome. (F) The association between the level of conjugation and the number of mutations in the human genome. (G) The association between the level of conjugation and the number of mutations in the human genome. (H) The association between the level of conjugation and the number of mutations in the human genome. (I) The association between the level of conjugation and the number of mutations in the human genome. (J) The association between the level of conjugation and the number of mutations in the human genome. (K) The association between the level of conjugation and the number of mutations in the human genome. (L) The association between the level of conjugation and the number of mutations in the human genome. (M) The association between the level of conjugation and the number of mutations in the human genome. (N) The association between the level of conjugation and the number of mutations in the human genome. (O) The association between the level of conjugation and the number of mutations in the human genome. (P) The association between the level of conjugation and the number of mutations in the human genome. (Q) The association between the level of conjugation and the number of mutations in the human genome. (R) The association between the level of conjugation and the number of mutations in the human genome. (S) The association between the level of conjugation and the number of mutations in the human genome. (T) The association between the level of conjugation and the number of mutations in the human genome. (U) The association between the level of conjugation and the number of mutations in the human genome. (V) The association between the level of conjugation and the number of mutations in the human genome. (VI) The association between the level of conjugation and the number of mutations in the human genome. (VII) The association between the level of conjugation and the number of mutations in the human genome. (VIII) The association between the level of conjugation and the number of mutations in the human genome. (IX) The association between the level of conjugation and the number of mutations in the human genome. (X) The association between the level of conjugation and the number of mutations in the human genome. (XI) The association between the level of conjugation and the number of mutations in the human genome. (XII) The association between the level of conjugation and the number of mutations in the human genome. (XIII) The association between the level of conjugation and the number of mutations in the human genome. (XIV) The association between the level of conjugation and the number of mutations in the human genome. (VIII) The association between the level of conjugation and the number of mutations in the human genome. (IX) The association between the level of conjugation and the number of mutations in the human genome. (X) The association between the level of conjugation and the number of mutations in the human genome. (XI) The association between the level of conjugation and the number of mutations
Figure 2. Prevalence of mutations in RHEA rs1704358 and DDB1 rs1693856. (a) Gene expression profiles of the RHEA rs1704358 allele in human RA patients. (b) Gene expression profiles of the DDB1 rs1693856 allele in human RA patients. (c) Frequency of mutations in RHEA rs1704358, DDB1 rs1693856, and DDB1 rs1693856. (d) Association of gene expression profiles with disease severity. (e) Frequency of mutations in RHEA rs1704358, DDB1 rs1693856, and DDB1 rs1693856. (f) Association of gene expression profiles with disease severity. (g) Frequency of mutations in RHEA rs1704358, DDB1 rs1693856, and DDB1 rs1693856. (h) Association of gene expression profiles with disease severity. (i) Frequency of mutations in RHEA rs1704358, DDB1 rs1693856, and DDB1 rs1693856.
www.roadwenta.com www.tefal.com











